Researchers have identified a gene variant linked to psychotic symptoms and cognitive impairment in people with bipolar disorder.
A study in Sleep reports on a link between cognition, sleep and a metabolite called kynurenic acid. The metabolite has previously been linked to schizophrenia.
A link has been identified between psychosis and a genetic change that alters the immune system in the brain. Researchers found people with psychosis associated with bipolar disorder had decreased expression of GRK3. This led to an increased amount of kynurenic acid in the brain.
Researchers have identified a compound that appears to reverse the symptoms of Alzheimer's and Parkinson's disease in fruti flies. The findings may have significant implications for treating the diseases in humans.
Adjusting levels of KYNA can have a significant effect on schizophrenia symptoms, a new study reports.
Researchers report keeping levels of KYNA low throughout a worm's life can help prevent the onsite of age-related cognitive decline.